Microsoft’s next moves: Biz dev and strategy leader Christopher Young is focusing on these key areas

ALPHA10X : de l’IA pour réduire le risque lié à l’investissement dans les sciences de la vie

Pharmacoprint: A Combination of a Pharmacophore Fingerprint and Artificial Intelligence as a Tool for Computer-Aided Drug Design

AION Labs, Biotech Innovation Lab Launched by Top Pharma, Tech and Investment Leaders

Investment Into Biosciences Boomed, Could The Bubble Burst?

French AI strategy: Tech sector to receive over €2 bln in next 5 years

Why AI is so difficult to apply in finance

Exscientia : Announces Closing of $510.4 Million Aggregate Financing, Consisting of $350.4 Million Upsized Initial Public Offering With Full Exercise of Underwriters' Option to Purchase Additional ADSs and $160.0 Million Concurrent Private Placement

Exscientia Files For $100M IPO

AI drug discovery platform raises Series B funding